Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 EUR | -2.37% | -4.00% | -64.00% |
Sales 2023 | 712K 758K | Sales 2024 * | 650K 692K | Capitalization | 40.67M 43.32M |
---|---|---|---|---|---|
Net income 2023 | -32M -34.09M | Net income 2024 * | -20M -21.3M | EV / Sales 2023 | 159 x |
Net Debt 2023 * | 11.85M 12.62M | Net Debt 2024 * | 47.5M 50.6M | EV / Sales 2024 * | 136 x |
P/E ratio 2023 |
-3.28
x | P/E ratio 2024 * |
-2.44
x | Employees | 70 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 76.24% |
Latest transcript on Sequana Medical N.V.
1 day | -2.37% | ||
1 week | -4.00% | ||
Current month | -4.32% | ||
1 month | -34.55% | ||
3 months | -48.75% | ||
6 months | -48.39% | ||
Current year | -64.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 15-12-31 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 22-07-18 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 18-11-07 |
Ids van der Weij
BRD | Director/Board Member | - | Nov. 09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.44 | -2.37% | 13,450 |
24-04-18 | 1.475 | +3.51% | 45,686 |
24-04-17 | 1.425 | +0.71% | 50,039 |
24-04-16 | 1.415 | -5.35% | 27,009 |
24-04-15 | 1.495 | -0.33% | 76,208 |
Real-time Euronext Bruxelles, April 19, 2024 at 10:17 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.00% | 43.38M | |
-1.42% | 41.52B | |
+42.15% | 39.9B | |
+1.97% | 38.83B | |
-14.19% | 26.05B | |
+1.82% | 23.78B | |
-24.55% | 18.26B | |
-4.07% | 11.65B | |
+21.36% | 11.53B | |
+8.20% | 11.2B |
- Stock Market
- Equities
- SEQUA Stock